Alternatives to Alagene

Global life sciences company providing diagnostic and biopharma laboratory services.

A global contract research organization providing essential drug discovery and development services.

Clinical research organization providing software and data analytics for drug development.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

AI-powered insights platform for life sciences and biotech workflows.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Cloud-based platform for reproducible computational research in life sciences.

Developing advanced plant-based ingredients for more resilient and nutritious food systems.

Develops Array Cytometry technology for large-scale dynamic single-cell response acquisition and predictive modeling.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

AI-driven platform for protein-level disease mapping and drug discovery.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

AI-powered blood test for early cancer detection and subtyping.

Synthetic biology platform for environmental sustainability solutions.

AI-powered epiproteomic analysis platform for mass spectrometry data.

Compressing biology to develop the next generation of therapies.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

Developing sex reversal technology for the broiler industry to improve economic efficiency and increase male broiler production.

Stealth mode startup in life sciences and synthetic biology.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Leveraging proteomics and machine learning for improved immunotherapy decisions and drug discovery.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

AI-powered platform for designing novel molecular structures for new medicines.

DenovAI Biotech leverages AI for de novo protein design, focusing on novel therapeutics and diagnostics.

Drug discovery and development company using a novel technological approach.

Life science company pioneering drug discovery with AI and advanced technologies.

Develops novel oral RNA delivery platforms for aquaculture health management, focusing on disease resistance.

Celleste Bio produces high-value cocoa ingredients using cell culture, bypassing traditional agriculture.

Revolutionary technology enabling cultured meat at price parity with animal meat.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

Unleashing the power of genomics at scale for biological advances and human health.

Computational biology company revolutionizing life sciences product discovery and development using predictive biology.

Cellular agriculture company creating climate-resilient cacao for sustainable chocolate production.

Global venture capital firm backing ambitious entrepreneurs from seed to IPO across technology and life sciences.

AI-driven digital twin of embryo development for cell-based therapies.

Arrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.

Developing a semiconductor-based protein detector using nanopore sensing for advanced identification.

Life sciences data platform for deep-phenotype multi-omics datasets.

Genomic and data science company developing novel drugs based on natural resistance mechanisms.

Biosynthesis of cannabinoids and psychedelics using advanced biotechnology.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Developing novel therapeutics for rare genetic diseases.

Advanced infectious disease diagnostics

AI-powered platform accelerating biological research and drug discovery.

Biopharmaceutical startup developing novel therapies for rare genetic diseases.

Developing universal donor-free red blood cells for life-saving transfusions and advanced therapies.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

VI Therapeutics is developing novel therapies for rare genetic diseases.

Develops enzyme technology to convert industrial sugars into rare sugars for reduced-calorie food products.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Omnix Medical is developing a novel platform for advanced wound care management.

Computational biology platform for optimizing IVF success rates and reducing treatment burdens.